Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Teva Pharmaceutical Industries Dividend Announcement
• Teva Pharmaceutical Industries announced a quarterly dividend of $0.09 per ordinary share which will be made payable on 2017-12-12. Ex dividend date: 2017-11-27
• Teva Pharmaceutical Industries's trailing twelve-month (TTM) dividend yield is -%
Teva Pharmaceutical Industries Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2017-11-27 | $0.09 | quarterly | 2017-12-12 |
2017-08-25 | $0.09 | quarterly | 2017-09-14 |
2017-06-01 | $0.34 | quarterly | 2017-06-22 |
2017-02-28 | $0.34 | quarterly | 2017-03-20 |
2016-12-01 | $0.34 | quarterly | 2016-12-20 |
2016-08-18 | $0.34 | quarterly | 2016-09-08 |
2016-05-20 | $0.34 | quarterly | 2016-06-07 |
2016-02-25 | $0.34 | quarterly | 2016-03-14 |
2015-11-13 | $0.34 | quarterly | 2015-12-03 |
2015-08-18 | $0.34 | quarterly | 2015-09-03 |
2015-05-15 | $0.34 | quarterly | 2015-06-04 |
2015-02-17 | $0.34 | quarterly | 2015-03-03 |
2014-11-13 | $0.32 | quarterly | 2014-12-02 |
2014-08-19 | $0.35 | quarterly | 2014-09-04 |
2014-05-16 | $0.35 | quarterly | 2014-06-02 |
2014-02-20 | $0.34 | quarterly | 2014-03-10 |
2013-11-18 | $0.33 | quarterly | 2013-12-03 |
2013-08-16 | $0.32 | quarterly | 2013-09-03 |
2013-05-16 | $0.32 | quarterly | 2013-06-03 |
2013-02-19 | $0.31 | quarterly | 2013-03-07 |
2012-11-13 | $0.26 | quarterly | 2012-12-03 |
2012-08-13 | $0.25 | quarterly | 2012-09-04 |
2012-05-17 | $0.26 | quarterly | 2012-06-04 |
2012-02-23 | $0.27 | quarterly | |
2011-11-09 | $0.22 | quarterly | 2011-12-07 |
2011-08-04 | $0.23 | quarterly | 2011-08-25 |
2011-05-19 | $0.23 | quarterly | 2011-06-07 |
2011-02-10 | $0.21 | quarterly | 2011-03-07 |
2010-11-08 | $0.19 | quarterly | 2010-12-06 |
2010-08-02 | $0.18 | quarterly | 2010-08-26 |
2010-05-10 | $0.19 | quarterly | |
2010-02-19 | $0.19 | quarterly | |
2009-11-06 | $0.16 | quarterly | |
2009-08-03 | $0.15 | quarterly | |
2009-05-08 | $0.14 | quarterly | |
2009-02-23 | $0.15 | quarterly | |
2008-11-07 | $0.12 | quarterly | |
2008-08-01 | $0.13 | quarterly | |
2008-05-13 | $0.13 | quarterly | |
2008-02-15 | $0.12 | quarterly | |
2007-11-02 | $0.10 | quarterly | |
2007-08-10 | $0.09 | quarterly | |
2007-05-10 | $0.10 | quarterly | |
2007-02-16 | $0.09 | quarterly | |
2006-11-10 | $0.08 | quarterly | |
2006-08-11 | $0.08 | quarterly | |
2006-05-12 | $0.08 | quarterly | |
2006-03-06 | $0.07 | quarterly |
Teva Pharmaceutical Industries Dividend per year
Teva Pharmaceutical Industries Dividend growth
Teva Pharmaceutical Industries Dividend Yield
Teva Pharmaceutical Industries current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Teva Pharmaceutical Industries stock? Use our calculator to estimate your expected dividend yield:
Teva Pharmaceutical Industries Financial Ratios
Teva Pharmaceutical Industries Dividend FAQ
Other factors to consider when evaluating Teva Pharmaceutical Industries as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Teva Pharmaceutical Industries stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Teva Pharmaceutical Industries's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Teva Pharmaceutical Industries publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Teva Pharmaceutical Industries distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Teva Pharmaceutical Industries are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Teva Pharmaceutical Industries sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Teva Pharmaceutical Industries distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Teva Pharmaceutical Industries declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Teva Pharmaceutical Industries's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Teva Pharmaceutical Industries's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.